Evidence map›Paper›PMID 30609983›Full record

Trial reportJMIR mHealth and uHealth2019

Mobile Phone-Based Telemedicine Practice in Older Chinese Patients with Type 2 Diabetes Mellitus: Randomized Controlled Trial.

Chenglin Sun, Lin Sun, Shugang Xi, Hong Zhang, Huan Wang, Yakun Feng, Yufeng Deng, Haimin Wang, Xianchao Xiao, Gang Wang and 2 more

3 registry-linked trialsOpen access · goldAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in JMIR mHealth and uHealth, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 78 papers, 25 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed, 25 pooled it
17.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05541120 nawithdrawnnot on this mapstarted 2022, after this paper: background citation

Effect of Remote Patient Monitoring and Patient Education on Patient Activation and Glycemic Control in Individuals With Type 2 Diabetes

TypeinterventionalSponsorTracy Jalbuena MDRan2022 to 2026Enrolled0ConditionsDiabetes Mellitus, Type 2ArmsRemote Patient Monitoring
NCT06178094 nacompletednot on this mapstarted 2022, after this paper: background citation

The Effects of Video Training Given to Individuals With Type 2 Diabetes Through Smartphones on Self-Care and Metabolic Control

TypeinterventionalSponsorKırklareli UniversityRan2022 to 2022Enrolled112ConditionsDiabetes Mellitus, Type 2, TrainingArmsVideo Training
NCT06957093 narecruitingnot on this mapstarted 2025, after this paper: background citation

Evaluation of the Therapeutic Efficacy and Safety of Artificial Intelligence-based Decision-making Technology in the Integrated Management of Diabetes Mellitus: a Longitudinal, Open-labeled, Randomized Controlled Trial

TypeinterventionalSponsorThe First Hospital of Jilin UniversityRan2025 to 2026Enrolled400ConditionsDiabetes Mellitus Type 2 (T2DM), Artificial Intelligence (AI)Armsartificial intelligence, Routine diagnosis and treatment group for diabetes
3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 25 syntheses or guidelines pooled it, 143 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Pooled it
  5. Digital Therapeutics in China: Comprehensive Review.Journal of medical Internet research · 2025
    Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Pooled it
  15. Pooled it
  16. Pooled it
  17. Pooled it
  18. Pooled it
  19. Pooled it
  20. Pooled it

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Chenglin Sun *Department of Endocrinology, First Hospital of Jilin University, Changchun, China.ORCID 0000-0003-3570-1918
Lin Sun *Department of Endocrinology, First Hospital of Jilin University, Changchun, China.ORCID 0000-0003-2218-0527
Shugang Xi *Department of Endocrinology, First Hospital of Jilin University, Changchun, China.ORCID 0000-0001-9939-8212
Hong ZhangDepartment of Endocrinology, First Hospital of Jilin University, Changchun, China.ORCID 0000-0002-9054-0865
Huan WangDepartment of Endocrinology, First Hospital of Jilin University, Changchun, China.ORCID 0000-0003-4683-963X
Yakun FengHealth Management Center, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.ORCID 0000-0003-0130-042X
Yufeng DengDepartment of Endocrinology, First Hospital of Jilin University, Changchun, China.ORCID 0000-0002-4674-3606
Haimin WangDepartment of Endocrinology, First Hospital of Jilin University, Changchun, China.ORCID 0000-0003-0724-924X
Xianchao XiaoDepartment of Endocrinology, First Hospital of Jilin University, Changchun, China.ORCID 0000-0002-1253-0290
Gang WangDepartment of Endocrinology, First Hospital of Jilin University, Changchun, China.ORCID 0000-0002-2443-0991
Yuan GaoDepartment of Endocrinology, First Hospital of Jilin University, Changchun, China.ORCID 0000-0001-5534-495X
Guixia WangDepartment of Endocrinology, First Hospital of Jilin University, Changchun, China.ORCID 0000-0001-9885-225X
Jilin University · CNFirst Affiliated Hospital of Zhengzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrevious studies on telemedicine interventions have shown that older diabetic patients experience difficulty in using computers, which is a barrier to remote communication between medical teams and older diabetic patients. However, older people in China tend to find it easy to use mobile phones and personal messaging apps that have a user-friendly interface. Therefore, we designed a mobile health (mHealth) system for older people with diabetes that is based on mobile phones, has a streamlined operation interface, and incorporates maximum automation.

objectiveThe goal of the research was to investigate the use of mobile phone-based telemedicine apps for management of older Chinese patients with type 2 diabetes mellitus (T2DM). Variables of interest included efficacy and safety.

methodsA total of 91 older (aged over 65 years) patients with T2DM who presented to our department were randomly assigned to one of two groups. Patients in the intervention group (n=44) were provided glucometers capable of data transmission and received advice pertaining to medication, diet, and exercise via the mHealth telemedicine system. Patients assigned to the control group (n=47) received routine outpatient care with no additional intervention. Patients in both groups were followed up at regular 3-month intervals.

resultsAfter 3 months, patients in the intervention group showed significant (P<.05) improvement in postprandial plasma glucose level. After 6 months, patients in the intervention group exhibited a decreasing trend in postprandial plasma glucose and glycated hemoglobin levels compared with the baseline and those in the control group (P<.05).

conclusionsMobile phone-based telemedicine apps help improve glycemic control in older Chinese patients with T2DM.

trial registrationChina Clinical Trial Registration Center ChiCTR 1800015214; http://www.chictr.org.cn/showprojen.aspx?proj=25949 (Archived by WebCite at http://www.webcitation.org/73wKj1GMq).

Indexed as

AgedAged, 80 and overBlood Glucose Self-MonitoringCell PhoneChinaDiabetes Mellitus, Type 2FemaleHumansMaleMobile ApplicationsTelemedicinehealth managementtelemedicinetype 2 diabetes

Identifiers

PMID30609983
PMCPMC6682265
OpenAlexW2897459611

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.